Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 

Discover how researchers are using flow cytometry to delve into the inner workings of the immune life cycle!

Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.

An absence of germinal centers—which arise during infections to produce long-lived antibody-generating cells—might explain rapidly waning antibody levels in the disease.

A B-cell receptor critical for the production of a subset of intestinal antibodies has been pinpointed, but the function of those antibodies remains unclear.

Scientists are examining the role of T cells, which are likely crucial for long-term protection against SARS-CoV-2.

Studies are underway to test whether giving a shot of BCG vaccine could protect doctors and nurses against COVID-19.

Studies from serum samples could transform our understanding of the spread of COVID-19, but what antibodies alone say about immunity is not yet clear.

A small study of macaques finds they don’t develop a coronavirus infection the second time they are exposed, supporting the idea of using plasma from recovered patients as a treatment for COVID-19.